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Abstract
Background: Tart Montmorency cherries contain high concentrations of phytochemicals and anthocyanins, which
have recently been linked to improved athletic recovery and subsequent performance. To date however, previous
work reporting promising results has focused on land-based endurance sports, with any potential benefits to team
sports remaining unknown. As such, this investigation set-out to examine the effect of supplemental tart cherry juice
(CJ) on recovery and next day athletic performance in highly-trained water-based team sport athletes over seven days.
Methods: In a randomised, double-blind, repeated measures, crossover design, nine male Water Polo athletes
were supplemented with CJ or a placebo equivalent (PLA) for six consecutive days. Prior to, and at the completion of
the supplementation period, water-based performance testing was conducted. On day 6, participants also undertook a
fatiguing simulated team game activity. Venous blood samples were collected (Pre-exercise: day 1, 6 and 7;
Post-exercise: day 6) to investigate markers of inflammation [Interleukin-6 (IL-6); C-reactive protein (CRP)] and
oxidative stress [Uric Acid (UA); F2-Isoprostane (F2-IsoP)]. A daily diary was also completed (total quality of
recovery, delayed onset muscle soreness) as a measure of perceptual recovery.
Results: In both conditions, day 6 post-exercise IL-6 was significantly higher than pre-exercise and day 7 (p < 0.05);
CRP was greater on day 7 as compared to day 6 pre- and post-exercise (p < 0.05); F2-IsoP was significantly lower on
day 7 as compared to day 1 and day 6 (p < 0.05); UA remained unchanged (p > 0.05). No differences were found for
any performance or recovery measures.
Conclusions: The lack of difference observed in the blood markers between groups may reflect the intermittent,
non-weight bearing demands of Water Polo, with such activity possibly unable to create a substantial inflammatory
response or oxidative stress (over 7 days) to impede performance; thereby negating any potential beneficial effects
associated with CJ supplementation.
Trial registration: This trial was registered with the Australian and New Zealand Clinical Trials Registry (ANZCTR).
Registration number: ACTRN12616001080415. Date registered: 11/08/2016, retrospectively registered.
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Background
Tart Montmorency cherries have recently gained repute
as a useful supplement for athletes due to their high
concentration of phytochemicals and anthocyanins,
which have been linked to numerous health benefits.
These include high anti-inflammatory and anti-oxidant
capacities, enhanced sleep, improved recovery and a re-
duction in post-exercise muscle damage and soreness
[1–3]. Such findings have recently led to tart cherry juice
(CJ) being included as a ‘Group B’ supplement (warrants
further research/provided to athletes within research or
clinical monitoring situations) on the Australian Institutue
of Sport Supplement Classification System. To date how-
ever, all exercise-based studies have investigated the ef-
fects of CJ supplementation on recovery from maximal
strength or endurance (>60 min duration) exercise, dem-
onstrating an attenuation of markers related to both in-
flammation and oxidative stress [2, 4, 5]. As such, any
response linked to accelerated recovery would appear
beneficial when considering the large training load experi-
enced by high performance athletes.
Despite the aforementioned benefits of tart CJ supple-
mentation, its effect on performance, inflammation and
oxidative stress in water-based team sport athletes re-
mains unknown. Specifically, the non-weight bearing
intermittent nature of Water Polo may influence the typ-
ical post-exercise inflammatory and oxidative stress re-
sponse (compared to endurance exercise), thus having
implications for the type of recovery strategies adopted
by such populations. Therefore, the aim of this investiga-
tion was to assess the effect of supplemental tart CJ on
athletic recovery and next day performance in highly-
trained Water Polo players. It was hypothesised that tart
CJ supplementation (in comparison to a placebo [PLA]
equivalent) would; (a) improve athletic performance, and
(b) reduce post-exercise markers of inflammation, oxida-
tive stress and perceptual muscle soreness.
Methods
Subject background and preparation
Nine highly-trained male Water Polo players were re-
cruited from the Western Australian Institute of Sport
(WAIS) Water Polo squad. The mean (± SD) physical
characteristics of the participants were; age: 18.6 (±1.4)
years, body mass: 82.7 (±9.8) kg and Σ7 skin-folds: 70.7
(±29.7) mm. All players were provided with an informa-
tion sheet outlining the procedures, potential risks and
benefits of the study prior to signing an informed con-
sent agreement to participate. In the event that the par-
ticipant was under the age of 18 years, signed consent
was obtained from the individuals’ parent or legal guard-
ian. Approval for the study was obtained from the
Human Research Ethics Committee at the University of
Western Australia (RA/4/1/7380).
Experimental overview
A randomised double-blind, repeated measures, crossover
design was employed to assess the influence of the tart CJ
supplementation versus the PLA. The investigation con-
sisted of two experimental trials, each involving a 7-day
protocol. A 5-week washout period was adopted between
the two experimental trials to preclude any follow-on ef-
fects, based on comparable previous supplementation re-
gimes [6, 7]. During the experimental trials, participants
were supplemented with CJ or a PLA equivalent from day
1 to day 6. On day 1, prior to the supplementation period,
water-based performance testing was conducted. No form
of physical activity was performed in the preceding 48 h of
day 1, with participants arriving at the laboratory at
05:00 am to provide a venous blood sample immediately
prior to commencing a standardised warm-up and the
testing battery. The swimming-based tests comprised of
the in-water vertical jump test (VJ), 10 m sprint test, the
repeat sprint test (RST) and the Water Polo Intermittent
Shuttle Test (WIST) [8], completed in the aforementioned
order. All test protocols were conducted in accordance
with the Australian National Water Polo Test Protocols
[9, 10]. Capillary blood samples were collected to measure
blood lactate levels (BLa) following the RST and WIST
using a Lactate Pro II analyser (Arkray, Japan). All testing
sessions were performed in a heated indoor Water Polo
pool (27.5 °C). The testing battery was conducted in the
morning (identical to typical training times) to minimise
any diurnal influence on the test outcomes.
Throughout each experimental trial, participants had a
fixed training regime (Table 1). All training (technical
skill, weights, and swimming) performed during the 7-
day trials was identical, and took place in the controlled
environment of the indoor Water Polo pool or gymna-
sium. Training duration and a rating of perceived exer-
tion (RPE) were collected after each training session to
establish a quantified training load (RPE x Session Dur-
ation; [11]). The average daily training load was similar
between trials (p > 0.05), at 561 ± 108 arbitrary units
(AU) and 572 ± 89 AU for the CJ and PLA conditions,
respectively. Participants also completed a comprehen-
sive online daily diary for the duration of each experi-
mental trial in order to assess their perceived recovery.
On day 6, participants attended the laboratory at
15:45 pm to provide a venous blood sample immediately
prior to undertaking a simulated fatiguing team game
activity, designed to replicate the demands of a Water
Polo match [12]. A post-exercise venous blood sample
was collected upon completion of the simulation. Finally,
on day 7 of the supplementation period, participants ar-
rived at the laboratory at 07:30 am to provide a final
venous blood sample. Immediately thereafter, the ath-
letes were required to re-perform the water-based per-
formance tests as per day 1.
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Venous blood samples collected throughout each experi-
mental trial were used to investigate biological markers in-
dicative of the efficacy of CJ. Inflammatory markers [high
sensitivity (hs) IL-6 and CRP] were measured on day 6
(pre- & post-match simulation) and day 7 (12 h post-
match simulation) of each testing week. Markers of oxida-
tive stress [Uric acid (UA) and F2 isoprostane (F2-IsoP)]
were measured at all 4 venous blood sampling time points;
day 1 (pre-performance testing), day 6 (pre- & post-match
simulation), and again on day 7 (pre-performance testing).
Experimental procedures
Cherry juice supplementation
Participants consumed 90 mL daily of tart Montmorency
CJ (Prunus Cerasus) concentrate (Cherry Active, Sunbury,
UK) or a PLA equivalent for a total of 6 days. The cherry
concentrate was diluted with water, such that each 30 mL
serving was made up into a 200 mL beverage. Both the CJ
and PLA were consumed in two doses each day; 200 mL
before morning training, and 400 mL in the evening post-
training. According to the manufacturer, a 30 mL dose of
Cherry Active concentrate is equivalent to approximately
90 whole Montmorency tart cherries (Cherry Active,
Sunbury, UK) containing 9.117 mg/mL of anthocyanins,
which has previously been reported to have positive health
and performance outcomes [4, 6, 13].
The PLA was made by combining 40 mL of three differ-
ent ‘off the shelf ’ cordials. Lime (Woolworths select lime
cordial, Australia), cranberry (Bickford’s cranberry juice
cordial, Australia) and raspberry (Cottee’s raspberry fla-
voured cordial, Australia) cordials were mixed with food
colouring and 480 mL of water in order to closely imitate
the taste, colour and carbohydrate content (10 g/100 mL,
maltodextrin powder, Nutricia Poly-Joule, Australia) with-
out any of the anthocyanin content of the CJ. Daily adher-
ence to supplement consumption was made by the
investigators being present at every session.
Performance tests and match simulation
Testing battery
As previously highlighted, all four performance tests (VJ,
10 m sprint, RST, WIST) were specifically selected based
on their ability to assess important traits of Water Polo
[8–10]. A minimum of 5 min rest between each test was
also adopted to ensure adequate recovery. The VJ test re-
quired participants to propel themselves as high out of the
water as possible, extending their arms and fingers directly
upward at the peak of the jump to displace as many vanes
on a customised Water Polo specific Yardstick®; with the
Table 1 Training schedule from day 1 to day 6 for both the cherry juice and placebo trial weeks
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
AM Testing battery Weights Swim set Weights Training Weights Testing battery
VJ Sumo deadliftA Kick set Back squatA Swim set (3.3 km) Barbell step-upA VJ
10 m sprint Bench pressA Freestyle Push press dumbbell Passing Dumbbell bench
pressA
10 m sprint
RST Bench throw in
smith machineB
Breaststroke Push press medicine
ballD
Game play Bench pull: drop
& catchE
RST
WIST Medicine ball chest
pass
Backstroke Pallof pressA Shoulder external
rotationF
WIST
Chin-upsA (Total: 5 km, 90 min) Single arm rowA Kneeling chopG
One arm kettlebell
side bendsC
Oblique twist with
kettlebellC
(90 min) Lateral pulldownG
PM Training Training Rest Training Rest Match simulation -
Swim drills Swim drills Swim drills (1.8 km) Warm-up -
Passing drills Passing drills Medicine ball holds 8 × 5 min quarters -
Leg strength Leg strenght Wrestling Cool down -
Shooting Shooting Game play (60 min) -
Game play Game play (90 min) -
(120 min) (90 min) -
S Sets, R Repititions, RM Repitition max, BW Body weight
(A) 4S × 4R at 75–80% 1RM
(B) 3S × 5R at ~50% BW
(C) 2S × 10R at 10–12 kg
(D) 3S × 5R at 10 kg
(E) 2S × 10R at 60% 1RM
(F) 3S × 10R at 4 kg
(G) 3S × 10R at ~30% BW
McCormick et al. Journal of the International Society of Sports Nutrition  (2016) 13:41 Page 3 of 8
best attempt of three trials recorded. The 10 m sprint
(best of two trials) required participants to swim between
two ropes held just above water level at 0 and 10 m (that
were raised/lowered by the research team). Similar in de-
sign to the 10 m sprint, the RST consisted of 6 × 10 m
sprints departing every 17 s between the 0 and 10 m
ropes. A digital video camera (Sony HDR-HC9, Japan)
filming at 50 Hz was positioned on the opposite side of
the pool, with the viewing width set to ensure both start
and finish markers were clearly visible. Before testing, a
calibration rope was also filmed allowing virtual lines to
be accurately overlaid onto the video analysis program
(Dartfish, Australia) at both 0 and 10 m for the accurate
calculation of sprint time. Finally, WIST may be consid-
ered the water specific equivalent of the land-based Yo-Yo
intermittent recovery test [9, 10]. The WIST lasts approxi-
mately 14 min in total (for this population) and consists of
repeated 2 × 7.5 m shuttles (swims out and back) at pro-
gressively increasing speeds, interspaced by 10 s of recov-
ery (treading water) that is controlled by audio signals.
The protocols, validity and reliability of the water-based
testing schedule have been previously established, and are
currently adopted by Water Polo Australia [9]. Finally,
specific details of the match simulation protocol have pre-
viously been reported [12]. The purpose of use here was
solely to function as a fatiguing mechanism.
Daily diaries
On waking, athletes provided a Total Quality of Recovery
(TQR) rating and Delayed Onset Muscle Soreness
(DOMS) score for the upper body, upper legs, lower legs
and overall body. The TQR measured how well athletes felt
they had recovered, and encompassed the anchor points 6
(very, very poor recovery) to 20 (very, very good recovery)
[14]. The DOMS scale was included to measure how sore
athletes felt, encompassing the anchor points of 0 (normal;
without pain or stiffness) to 10 (very painful) [15].
Blood analysis
Venous blood was collected from an antecubital vein
using a 21-gauge needle into an 8 ml gel separator tube.
All samples were subsequently centrifuged at 10 °C for
10 min at 3000 rpm, and stored in 1.5 mL eppendorfs at
−80 °C until further analysis at a commercial pathology
laboratory (PathWest Laboratory, Fiona Stanley Hospital).
The IL-6 was analysed via immunoassay technique
(Quantikine HS ELISA, R&D Systems, Inc. Minneapolis,
USA). The coefficient of variation (CV) for inter-assay
precision at 0.49 and 2.78 pg/mL was 9.6 and 7.2%
respectively. The hsCRP was measured using an Architect
analyser (ci8200), and determined using a CRP Vario
Reagent (SENTINEL CH. SpA, Via Robert Koch, 2, Milan
20152, Italy). The CV for CRP determination at 0.88, 2.21
and 6.22 mg/L was 2.3, 1.2 and 1.0%, respectively. The UA
was measured using an Architect analyser (ci8200), and
determined using a UA Reagent (Abbott Diagnostics, Ab-
bott Laboratories, Abbott Park, IL 60064, USA). The CV
for UA determination at 0.25 and 0.56 mg/L was 1.92 and
1.5%, respectively. F2-IsoP was analysed using an Agilent
6890 gas chromatograph coupled to an Agilent 5973 mass
selective detector. The mean total (free + esterified)
plasma F2-IsoP concentration was 952 ± 38 pmol/L, with a
within and between assay reproducibility of 8.0 and 5.6%,
respectively [16].
Statistical analysis
Results are expressed as mean (±SD) and were analysed
using a repeated measures analysis of variance (ANOVA)
to determine time, condition and interaction effects of
tart CJ on measures of recovery and performance. A
post-hoc paired samples t-test was used to determine
any differences between trials. The alpha level was ac-
cepted at p < 0.05.
Results
Blood variables
The levels of IL-6, CRP, UA and F2-IsoP are depicted in
Fig. 1 (a), (b), (c) and (d), respectively. For IL-6, CRP and
F2-IsoP, a significant time (p < 0.05), but no condition or
interaction effect, was apparent across the supplementa-
tion period. Specifically, IL-6 levels were significantly
greater (p < 0.05) on day 6 post-exercise as compared to
day 6 pre-exercise and day 7. Additionally, CRP levels
were significantly greater on day 7 as compared to those
measured on day 6 pre- and post-exercise (p < 0.05). Fur-
thermore, F2-IsoP levels were significantly lower (p < 0.05)
on day 7 as compared to those recorded on day 1 and day
6 pre- and post-exercise. Finally, no condition, time or
interaction effects were evident for UA.
Performance variables
Performance data for the numerous Water Polo tests are
shown in Table 2. No condition, time or interaction ef-
fects were found for the WIST, VJ, 10 m sprint and RST
scores achieved across the supplementation period.
However, analysis of post-WIST and RST BLa levels
showed a significant effect for time (p < 0.05) between
day 1 and day 7; such that BLa levels were significantly
lower on day 7 (p < 0.05) compared to day 1 across both
conditions.
Perceptual variables
Ratings of DOMS and TQR are displayed in Table 3. No
condition, time or interaction effects (p > 0.05) were
found for the respective ratings for the duration of CJ or
PLA supplementation.
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Discussion
The findings of this study show that 6 consecutive
days of tart CJ supplementation has no effect on ath-
letic performance or recovery in highly-trained Water
Polo athletes. This outcome is in contrast to previous
research, and in part, may be related to different dos-
age strategies, and the modality and duration of exer-
cise used here.
Previous research [2, 4] has shown CJ supplementation
to be beneficial to athletic recovery in various sporting
activities, reporting lower levels of the inflammatory
marker IL-6 in the post-exercise recovery period when
CJ was consumed. Specifically, Howatson et al. [2] found
post-exercise IL-6 levels to be ~50% lower in marathon
runners supplemented with CJ (2 × 240 ml serve of CJ
daily over 8 days; one serve contained ~600 mg of
Fig. 1 Levels of high sensitivity (a) Interleukin-6 (b) C-Reactive protein (c) Uric acid and (d) F2-Isoprostane on day 1 (D1), day 6 pre-exercise
(D6pre), day 6 post-exercise (D6post). #Significantly different to (a) D6pre and D7 (b) D6pre and D6post; and (d) D6pre and D6post, time-points
in both the CJ and PLA trials
Table 2 Mean (±SD) performance for Vertical Jump (VJ), Water Polo Intermittent Swim Test (WIST), Repeat Swim Test (RST) and
10 m sprint for the cherry juice and placebo condition on day 1 and day 7
Test variable Cherry juice Placebo
Day 1 Day 7 Day 1 Day 7
VJ Absolute (cm) 149 ± 7 150 ± 6 149 ± 6 150 ± 6
Decimal 10.0 ± 2.2 9.5 ± 2.0 9.9 ± 1.2 9.2 ± 1.7
WIST Distance (m) 655 ± 261 605 ± 239 643 ± 151 558 ± 203
BLa (mmol/L) 6.3 ± 1.8 4.2 ± 1.5a 5.2 ± 1.7 3.7 ± 1.4a
RST Total time (s) 37.09 ± 1.92 36.76 ± 0.75 36.90 ± 0.78 37.07 ± 1.16
Deficit time (s) 1.54 ± 0.70 1.50 ± 0.44 1.52 ± 0.61 1.56 ± 0.48
Decrement (%) 4.34 ± 1.97 4.25 ± 1.29 4.31 ± 1.81 4.58 ± 1.50
BLa (mmol/L) 4.2 ± 1.7 3.4 ± 0.7a 3.6 ± 0.6 3.3 ± 0.8a
10 m Sprint Total time (s) 5.56 ± 0.15 5.59 ± 0.22 5.48 ± 0.24 5.56 ± 0.15
aSignificantly different to Day 1 of each trial
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phenolic compounds and ~40 mg anthocyanins) when
compared to a PLA equivalent. Further, Bell, Walshe et al.
[4] demonstrated that post-exercise IL-6 concentration
was 200% lower in cyclists that were supplemented with
CJ (2 × 30 ml of Cherry Active concentrate for 7 days) as
compared to PLA, following 3 consecutive days of a simu-
lated cycling road race (daily duration of 101 min com-
prising 66 sprints of various lengths ranging from 5 to
15 s, 2 × 4 min and 1 × 5 min time-trials). Both studies
also reported reduced oxidative damage following exer-
cise when CJ was consumed; an outcome supported by
similar findings following maximal eccentric exercise [6].
To our knowledge, this is the first study examining the
effects of CJ supplementation on inflammation, oxidative
stress and next-day performance in team-sport athletes.
Contrary to our hypothesis (and previous research), this
study was unable to show a post-exercise attenuation in
circulating levels of IL-6 and CRP, nor any influence on
post-exercise oxidative stress with supplementary CJ.
Such findings may be linked to the magnitude of inflam-
mation, oxidative stress and muscle damage induced
here, potentially being substantially lower when com-
pared to previous studies. Possibly, the mechanical strain
induced by Water Polo activity is likely to have been
lower when compared to endurance running [2] or cyc-
ling [4] efforts, as a result of the weight-supported and
intermittent nature of the activity performed. In support
of this notion, Nieman et al. [17] suggested that the
mechanical trauma incurred during exercise significantly
modulates the magnitude of the inflammatory response;
possibly explaining why post-exercise IL-6 levels have
been reported ~40 times higher [2], and CRP levels re-
ported ~6 times higher [4], than those reported after the
simulated Water Polo match completed here. Contrary
to our results, these studies suggest that any activity
resulting in high levels of inflammation or muscle dam-
age, such as marathon running (where IL-6 and CRP
were ~50 and 35% lower with CJ, respectively [2]) or en-
durance cycling (where IL-6 and CRP ~50 and 80%
lower with CJ, respectively [4]), would still benefit from
CJ supplementation. However, the smaller degree of
inflammation induced in our participants could poten-
tially have been inadequate to have benefitted from any
anti-inflammatory effects provided by the CJ supplemen-
tation. Additionally, the activity profile of Water Polo is
significantly different to endurance exercise, consisting of
a more intermittent activity pattern where players com-
monly perform ~100 sprint efforts of 7–14 s, interspersed
by lower intensity activity over the duration of a match
[18]. When related to markers of oxidative stress, the only
somewhat comparable previous study adopted a high-
intensity, intermittent cycling protocol (three sets of 9 ×
5 s departing every 25 s) and observed a similar response
for F2-IsoP [19]. Nevertheless, our results highlight the
possibility that any associated benefits of CJ on perform-
ance/recovery may only be present in sports where substan-
tially higher levels of inflammation and muscle damage
might occur. To this end, future research should examine
the efficacy of CJ supplementation on athletic performance
and recovery in running-based (weight-bearing) team sports
such as football, netball, hockey or rugby.
Reduced inflammation and oxidative stress post-
exercise allows for the maintenance of muscular func-
tion and likely mitigates soreness, possibly explaining
the preservation and recovery of strength found in previ-
ous studies where CJ was consumed [7]. That said, the
lack of difference between the CJ and PLA groups on
ratings of DOMS and TQR in the current study are
likely due to the lack of inflammation and oxidative
stress induced. These results are in contrast to the
findings of Connolly et al. [7], who found that when par-
ticipants performed repeated maximal eccentric contrac-
tions of their elbow flexors, the development of soreness
(rated on a scale of 1 to 10) was significantly diminished
in the group supplemented with commercially available
CJ (~350 ml daily of Cherrypharm for a total of 8 days)
as compared with the PLA. These authors also found
that maximal isometric strength loss was attenuated in
the 96 h following the CJ supplementation (4% vs. 22%
decrement for the CJ vs. PLA supplement, respectively).
Of interest, our results concur with Howatson et al. [2],
who found no significant differences in muscle soreness
in marathon runners that were supplemented with either
CJ or a PLA. However, due to the aforementioned differ-
ences in exercise modalities, duration, muscle damage
and inflammatory response between activities, it is diffi-
cult to make further definitive assumptions.
Another potential explanation for our results may be
the dosage protocol employed. Anti-inflammatory and
antioxidant effects have been found in marathon run-
ners supplemented for 5 days before and 2 days after a
race [2], and in cyclists supplemented for 4 days before
and on each of 3 subsequent time-trial days [4]. Unlike
these studies that continued to supplement during the
performance and recovery periods, our participants
Table 3 Mean (±SD) perceived ratings of Total Quality of
Recovery (TQR) and Delayed Onset Muscle Soreness (DOMS) for
the cherry juice and placebo condition on day 1 to day 6
Cherry juice Placebo
TQR DOMS TQR DOMS
Day 1 16 ± 3 3 ± 2 15 ± 3 3 ± 2
Day 2 15 ± 4 3 ± 2 15 ± 3 4 ± 2
Day 3 15 ± 3 3 ± 2 17 ± 2 3 ± 2
Day 4 15 ± 3 3 ± 2 13 ± 4 4 ± 2
Day 5 15 ± 3 3 ± 2 15 ± 3 3 ± 2
Day 6 16 ± 4 3 ± 2 15 ± 3 4 ± 2
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consumed their final CJ dose in the evening following
the Water Polo match simulation (day 6) prior to the
performance testing (morning of day 7), as we wanted
to specifically investigate next-day performance. Subse-
quently, this may have influenced the recovery out-
comes, since the levels of CRP often continue to rise to
a peak at 24 h post-exercise [2, 4]. However, it is sug-
gested that the supplementation duration (6 days) and
dosage (90 ml of CJ concentrate daily) used here would
have been sufficient to show any potential benefits. Our
dosage was equivalent to 270 cherries and 820 mg of
anthocyanins daily (accounting for Water Polo players
being heavier than endurance athletes) as opposed to
previous investigations where performance benefits
were recorded equating to a lower dose of 120 cherries
and 80 mg of anthocyanins daily [2].
A limitation of this investigation is that the anthocyanin
concentration of both the commercial and placebo sup-
plement used was not confirmed. However, the concentra-
tion of the active ingredient in the tart cherry juice
supplement used here has been previously published, and
was therefore used due to the positive results from this
research [4, 12]. Additionally, the placebo supplement was
selected because the manufacturer of these cordials sug-
gest there was no known anthocyanin content in their
products. Furthermore, no blood analysis of supplement
efficacy on increasing plasma anthocyanin levels was pos-
sible here; however, adherence to supplement consumption
was confirmed by direct investigator contact with athletes
at every training session. Regardless, future research must
further consider these points moving forward.
Conclusion
In summary, CJ supplementation had no significant effect
on the recovery of Water Polo specific athletic perform-
ance. Unlike previous research, the current study showed
no difference in anti-inflammatory or antioxidant activity
in athletes supplemented with CJ compared with the PLA,
thereby precluding any potential benefits to performance
or recovery in Water Polo players. As such, our results
suggest that CJ supplementation may not be necessary for
water-based non-weight bearing intermittent sports such
as Water Polo. Regardless, future research should examine
the use of CJ in other running-based weight-bearing team
sports before CJ can be recommended or excluded as an
effective mechanism to improve recovery and next-day
team sport performance.
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